Literature DB >> 25901618

Intractable bone marrow edema syndrome of the hip.

Fuqiang Gao, Wei Sun, Zirong Li, Wanshou Guo, Nepali Kush, Koji Ozaki.   

Abstract

There is a need for an effective and noninvasive treatment for intractable bone marrow edema syndrome of the hip. Forty-six patients with intractable bone marrow edema syndrome of the hip were retrospectively studied to compare the short-term clinical effects of treatment with high-energy extracorporeal shock wave therapy vs femoral head core decompression. The postoperative visual analog scale score decreased significantly more in the extracorporeal shock wave therapy group compared with the femoral head core decompression group (P<.05). For unilateral lesions, postoperative Harris Hip Scores for all hips in the extracorporeal shock wave therapy group were more significantly improved than Harris Hip Scores for all hips in the femoral head core decompression group (P<.05). Patients who underwent extracorporeal shock wave therapy also resumed daily activities significantly earlier. Average overall operative time was similar in both groups. Symptoms disappeared significantly sooner in the extracorporeal shock wave therapy group in patients with both unilateral (P<.01) and bilateral lesions (P<.05). Hospital costs were significantly lower with extracorporeal shock wave therapy compared with femoral head core decompression. The intraoperative fluoroscopy radiation dose was lower in extracorporeal shock wave therapy than in femoral head core decompression for both unilateral (P<.05) and bilateral lesions (P<.01). On magnetic resonance imaging (MRI), bone marrow edema improved in all patients during the follow-up period. After extracorporeal shock wave therapy, all patients remained pain-free and had normal findings on posttreatment radiographs and MRI scans. Extracorporeal shock wave therapy appears to be a valid, reliable, and noninvasive tool for rapidly resolving intractable bone marrow edema syndrome of the hip, and it has a low complication rate and relatively low cost compared with other conservative and surgical treatment approaches. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 25901618     DOI: 10.3928/01477447-20150402-53

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  10 in total

Review 1.  The use of extracorporeal shock wave therapy for the treatment of bone marrow oedema - a systematic review and meta-analysis.

Authors:  Jonathan Häußer; Juliane Wieber; Philip Catalá-Lehnen
Journal:  J Orthop Surg Res       Date:  2021-06-09       Impact factor: 2.359

2.  Bilateral Bone Marrow Edema Syndrome of the Femoral Head with a Unique Onset: A Case Report.

Authors:  Seung Rim Yi; Ye Hyun Lee; Hae Min Kim
Journal:  Hip Pelvis       Date:  2015-12-30

3.  Combined Therapy with Shock Wave and Retrograde Bone Marrow-Derived Cell Transplantation for Osteochondral Lesions of the Talus.

Authors:  Fuqiang Gao; Na Chen; Wei Sun; Bailiang Wang; Zhencai Shi; Liming Cheng; Zirong Li; Wanshou Guo
Journal:  Sci Rep       Date:  2017-05-18       Impact factor: 4.379

4.  Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study.

Authors:  Jiaming Zhou; Wuyi Xiong; Pengguo Gou; Zhao Chen; Xing Guo; Xiaoyang Huo; Yuan Xue
Journal:  J Orthop Surg Res       Date:  2020-06-23       Impact factor: 2.359

5.  Clinical and Radiological Outcomes of Extracorporeal Shock Wave Therapy in Early-Stage Femoral Head Osteonecrosis.

Authors:  Abdulrahman D Algarni; Hassan M Al Moallem
Journal:  Adv Orthop       Date:  2018-08-19

6.  The effects of shockwave therapy on musculoskeletal conditions based on changes in imaging: a systematic review and meta-analysis with meta-regression.

Authors:  Hani Al-Abbad; Sophie Allen; Susan Morris; Jackie Reznik; Erik Biros; Bruce Paulik; Anthony Wright
Journal:  BMC Musculoskelet Disord       Date:  2020-04-28       Impact factor: 2.362

7.  Extracorporeal shock wave therapy for bone marrow edema syndrome in patients with osteonecrosis of the femoral head: a retrospective cohort study.

Authors:  Wenyi Zhao; Yuan Gao; Shouxiang Zhang; Zhang Liu; Lin He; Dahong Zhang; Wei Li; Qinggang Meng
Journal:  J Orthop Surg Res       Date:  2021-01-07       Impact factor: 2.359

8.  Extracorporeal shock wave therapy in the treatment of primary bone marrow edema syndrome of the knee: a prospective randomised controlled study.

Authors:  Fuqiang Gao; Wei Sun; Zirong Li; Wanshou Guo; Weiguo Wang; Liming Cheng; Debo Yue; Nianfei Zhang; Amanda Savarin
Journal:  BMC Musculoskelet Disord       Date:  2015-12-05       Impact factor: 2.362

9.  Extracorporeal shock wave treatment can normalize painful bone marrow edema in knee osteoarthritis: A comparative historical cohort study.

Authors:  Shuhua Kang; Fuqiang Gao; Jun Han; Tianli Mao; Wei Sun; Bailiang Wang; Wanshou Guo; Liming Cheng; Zirong Li
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

10.  High-energy focused extracorporeal shock wave therapy for bone marrow edema syndrome of the hip: A retrospective study.

Authors:  Leilei Zhang; Yuzhi Cui; Dawei Liang; Jie Guan; Youwen Liu; Xiantao Chen
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.